Page last updated: 2024-09-05

sb 203580 and rvx 208

sb 203580 has been researched along with rvx 208 in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(rvx 208)
Trials
(rvx 208)
Recent Studies (post-2010) (rvx 208)
3,48941,137921389

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)rvx 208 (IC50)
Bromodomain-containing protein 4Homo sapiens (human)1.629
Bromodomain-containing protein 2Homo sapiens (human)2.9935
Bromodomain-containing protein 3Homo sapiens (human)1.5467
Bromodomain testis-specific proteinHomo sapiens (human)2.8167

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ayoub, AM; Berndt, N; Carlson, AS; Cui, H; Divakaran, A; Harki, DA; Mishra, NK; Pomerantz, WCK; Schonbrunn, EK; Talluri, SK; Topczewski, JJ; Widen, JC; Zhu, JY1

Other Studies

1 other study(ies) available for sb 203580 and rvx 208

ArticleYear
Molecular Basis for the N-Terminal Bromodomain-and-Extra-Terminal-Family Selectivity of a Dual Kinase-Bromodomain Inhibitor.
    Journal of medicinal chemistry, 2018, 10-25, Volume: 61, Issue:20

    Topics: A549 Cells; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Protein Domains; Protein Kinase Inhibitors; Water

2018